GoodRx Reports First Quarter 2025 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/25/2026
- Wall St ends mixed as tech megacap declines outweigh upbeat chip outlook
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- IBM surges on unveiling sub-1nm chip technology breakthrough
- 'Long-term deals significant positive for stock:' Analysts react to Micron results
- Two major earthquakes strike Venezuela, killing at least 32 and injuring hundreds
- Needham Starts NeoVolta (NEOV) at Buy
- Hertz cuts guidance, announces notes and stock offerings, shares sink
- Rockstar Games opens GTA VI pre-orders, priced at $79.99
- Rubio meets Gulf leaders, pledges security amid Iran deal doubts
GoodRx Holdings, Inc. (GDRX) Reports In-Line Q1 EPS, Beats on Revenue; Offers FY25 Revenue Guidance
May 7, 2025 4:45 PM EDTGoodRx Holdings, Inc. (NASDAQ: GDRX) reported Q1 EPS of $0.09, in-line with the analyst estimate of $0.09. Revenue for the quarter came in at $202.97 million versus the consensus estimate of $202.59 million.
GUIDANCE:
GoodRx Holdings, Inc. sees FY2025 revenue of $810-840 million, versus the... More
